Q All right. So tell us what recursion pharma, what kind of, what's your, your main product, your main focus, and what's your business model? How do you generate revenues?
A Yeah, absolutely. So what we're trying to do is shortcut the long, arduous, uh, path of getting, uh, drugs discovered into the market. Um, and so we do this by combining the best elements of biology, automation, and computation, uh, and doing drug discovery at scale across lots of diseases all in parallel. Uh, the business model initially has been to partner with large pharmaceutical companies who have drugs that they know a lot about, but ultimately did not end up making it to market. Um, so we've announced, for example, a partnership with Sanofi Genzyme, and in that particular case, we have drugs that, that, uh, they spent decades working on in many cases, and those drugs never ended up making it to patients, not because they're bad drugs, just because, uh, of a variety of business reasons, or even because the drug didn't show efficacy.
AI assessment note: “The business model initially has been to partner with large pharmaceutical companies”